tiprankstipranks
Clinuvel Pharmaceuticals Limited (CLVLF)
OTHER OTC:CLVLF
Holding CLVLF?
Track your performance easily

Clinuvel Pharmaceuticals Limited (CLVLF) Financial Statements

31 Followers

Clinuvel Pharmaceuticals Limited Financial Overview

Clinuvel Pharmaceuticals Limited's market cap is currently ―. The company's EPS TTM is $0.467; its P/E ratio is 15.86; and it has a dividend yield of 0.44%. Clinuvel Pharmaceuticals Limited is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $0.16. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total RevenueAU$ 41.40MAU$ 47.98MAU$ 32.57M--
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 121.51MAU$ 82.69MAU$ 66.75MAU$ 54.27MAU$ 36.20M
Total AssetsAU$ 143.95MAU$ 108.57MAU$ 81.54MAU$ 62.35MAU$ 42.90M
Total DebtAU$ 1.26MAU$ 1.30MAU$ 1.32MAU$ 432.52KAU$ 0.00
Net DebtAU$ -120.25MAU$ -81.39MAU$ -65.43MAU$ -53.84MAU$ -36.20M
Total Liabilities-----
Stockholders EquityAU$ 125.56MAU$ 98.74MAU$ 73.67MAU$ 57.18MAU$ 39.42M
Cash Flow-
Free Cash Flow-----
Operating Cash FlowAU$ 39.87MAU$ 16.20MAU$ 14.19M--
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Clinuvel Pharmaceuticals Limited Earnings and Revenue History

Clinuvel Pharmaceuticals Limited Debt to Assets

Clinuvel Pharmaceuticals Limited Cash Flow

Clinuvel Pharmaceuticals Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis